FLGT R&D to Revenue
Fulgent Genetics Inc · R&D to Revenue
FLGT R&D to Revenue
Latest reported17.04%period ending
FLGT Quarterly R&D/Revenue (13.66% → 17.04%)
Latest values, visible window
High-resolution chart · PNG
FLGT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 17.0443% | |
| 19.9275% | |
| 17.0035% | |
| 16.4865% | |
| 16.4786% | |
| 16.8724% | |
| 15.8934% | |
| 16.4239% | |
| 18.9869% | |
| 17.7313% | |
| 16.952% | |
| 11.8247% | |
| 14.2838% | |
| 14.7836% | |
| 12.5679% | |
| 7.1052% | |
| 5.509% | |
| 1.87% | |
| 2.9658% | |
| 2.6423% | |
| 3.458% | |
| 1.5085% | |
| 1.5513% | |
| 3.1234% | |
| 10.7095% | |
| 25.5127% | |
| 21.4022% | |
| 16.8551% | |
| 18.6847% | |
| 26.5177% | |
| 25.1101% | |
| 25.5644% | |
| 22.4444% | |
| 31.3346% | |
| 30.9274% | |
| 25.05% | |
| 19.8276% | |
| 16.0384% | |
| 13.9734% | |
| 30.3931% | |
| 16.5198% | |
| 16.3081% | |
| 125.7842% | |
| 10.7057% | |
| 11.6002% | |
| 13.665% |